Fig. 5: Overview of study design.

TIV trivalent influenza vaccine, LAIV live-attenuated influenza vaccine, IN intranasal, IM intramuscular, PBMC peripheral blood mononuclear cells, BML breast milk lymphocytes, DE differentially expressed, HAI hemagglutination inhibition, DMID Department of Microbiology and Infectious Diseases.